Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries

NCT ID: NCT06802419

Last Updated: 2025-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-30

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of Continuous Adductor Canal Block only versus adding posterior knee block, known as the Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block with Continuous Adductor Canal Block (CACB) after arthroscopic knee surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Enhanced recovery after arthroscopic knee surgery is gaining popularity in orthopedic surgeries. Motor preservation with adequate analgesia has become the optimal postoperative goal, enabling earlier physical therapy, faster recovery, and early hospital discharge. Spinal anesthesia for knee arthroscopy has favorable outcome effects compared with general anesthesia. The positive physiological effects of the provided sympathetic blockade with less blood loss, increased leg blood flow, and better initial pain relief explain this.

An ideal nerve block that targets the sensory nerves and spares the motor function can facilitate early ambulation and rehabilitation, a major goal for patients undergoing arthroscopic knee surgery.

A novel technique for posterior knee block, known as the infiltration between the popliteal artery and capsule of the knee (IPACK) block combined with continuous adductor canal block (CACB) would reduce opioid requirements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Continuous Adductor Canal Block Infiltration Between The Popliteal Artery and Capsule of The Knee Arthroscopic Knee Surgeries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Patients will receive continuous adductor canal block.

Group Type EXPERIMENTAL

Continuous adductor canal block

Intervention Type OTHER

Patients will receive continuous adductor canal block.

Group 2

Patients will receive Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule of The Knee

Group Type EXPERIMENTAL

Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule

Intervention Type OTHER

Patients will receive Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule of The Knee

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous adductor canal block

Patients will receive continuous adductor canal block.

Intervention Type OTHER

Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule

Patients will receive Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule of The Knee

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 21 to 65 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) Physical Status Class I to II.
* Patients with successful spinal anesthesia.
* Patients scheduled for elective arthroscopic knee surgery for anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) repair.

Exclusion Criteria

* Declining to give written informed consent.
* History of allergy to the medications used in the study.
* Contraindications to regional anesthesia (including coagulopathy and local infection).
* Polytrauma patients having lower limb fractures.
* Patients with pre-existing myopathy or neuropathy on the operating limb.
* Patients with diabetes mellitus.
* Psychiatric disorder.
* Morbid obesity \[body mass index (BMI) \> 45kg/m2\].
* Complicated Surgery.
Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nada Ezzat

Assistant Lecturer of Anesthesiology, Intensive Care and Pain Medicine, Faculty of Medicine, Ain shams University, Cairo, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nada E Hussein, Master

Role: CONTACT

00201112449418

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nada E Hussein, Master

Role: primary

00201112449418

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMASU MD134/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Knee Osteoarthritis and IPACK
NCT06712394 NOT_YET_RECRUITING